U.S. Fears for Patents on Next-Generation Drugs in India

Thursday, March 6, 2014

The United States on Thursday voiced concern over protection of patents on safer and more effective next-generation medicines in India amid fears that authorities are considering allowing more Indian firms to make new varieties of cheap generic drugs still on patent.

Source: The Chicago Tribune (link opens in a new window)

Categories
Entrepreneurship, Health Care
Tags
business development, drugs, global health, health care, pharmaceutical industry